台股 » 個股 » 易威 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

易威

(1799)
  • 股價
    66.6
  • 漲跌
    ▼0.9
  • 漲幅
    -1.33%
  • 成交量
    208
  • 產業
    上櫃 生技醫療類股
  • 71人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
易威 (1799)籌碼相關-凱基-高雄 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw05/0405/1806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1002/0402/1602/2603/1003/2004/0104/0355606570758085May '24Jul '24Sep '24Nov '24Jan '25Mar '2560d90dAll

凱基-高雄 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/03/28173.2000.0070.5015700.18%
2025/03/26076.0000.0074.7005770.00%
2025/03/24172.20172.2072.2005930.00%
2025/03/13179.3000.0081.0016030.17%
2025/03/1200.00179.0077.50-1585-0.17%
2025/03/1100.001077.3181.50-10557-1.79%
2025/03/101076.8000.0076.80105181.93%
2025/03/04068.9000.0069.6004830.00%
2025/02/21070.0000.0067.8005080.00%
2025/02/14162.1000.0063.0015430.18%
2025/01/13066.0000.0062.8006270.00%
2025/01/02164.0000.0064.2016430.16%
2024/12/3000.00166.7066.70-1692-0.14%
2024/12/25175.4000.0074.0016830.15%
2024/12/2400.00170.6073.00-1677-0.15%
2024/12/2300.00365.2066.40-3680-0.44%
2024/12/20162.0000.0060.4016840.15%
2024/12/19364.33160.8062.7026950.29%
2024/12/18158.00260.5060.90-1678-0.15%
2024/12/11254.9000.0054.9026660.30%
2024/12/05165.6000.0065.5016550.15%
2024/12/0300.00167.5067.80-1662-0.15%
2024/11/27267.5000.0066.5026770.30%
2024/11/2200.00274.5073.00-2672-0.30%
2024/11/21268.0000.0068.0026620.30%
2024/11/1400.000.267.0069.00-0.2670-0.02%
2024/11/130.163.8100.0064.000.16520.02%
2024/11/12063.4000.0070.0006320.00%
2024/09/271120.0000.00120.0017960.13%
2024/09/262133.0000.00133.0027850.25%
2024/09/233157.0000.00158.0037940.38%
2024/08/0900.0013180.50203.50-13824-1.58%
2024/08/062173.0000.00171.0027770.26%
2024/07/2900.001142.00141.50-1708-0.14%
2024/07/236162.5800.00160.0066850.87%
2024/07/195177.0000.00182.0056500.77%
2024/07/111154.0000.00149.0015310.19%
2024/07/1000.004149.00152.50-4512-0.78%
2024/07/0900.002138.50139.00-2499-0.40%
2024/07/0800.008137.31138.50-8493-1.62%
2024/07/0500.001126.00127.50-1480-0.21%
2024/07/022138.0000.00138.0024460.45%
2024/06/2700.001118.50118.50-1393-0.25%
2024/06/191100.5000.00101.5013740.27%
2024/06/182104.5000.00104.5023640.55%
2024/06/12298.0500.0097.4023270.61%
2024/06/06196.3000.0095.0013180.31%
2024/06/03593.3600.0093.0053151.59%
2024/05/30191.4000.0090.9013200.31%
2024/05/29195.3000.0094.5013190.31%
2024/05/2300.00398.83100.50-3286-1.05%
2024/05/2200.00293.2591.50-2260-0.77%
2024/04/23667.4000.0068.0062562.34%
易威慢性心臟衰竭用藥獲中國藥證 明年Q1底展開銷售Anue鉅亨-2023/10/30
美新行政令強化製藥在地化 易威、泰福-KY迎來新訂單Anue鉅亨-2022/09/20
〈易威法說〉策略轉型見成效 新藥、學名藥營收比重拚達7成Anue鉅亨-2021/12/17
易威 相關文章
易威 相關影音
 
 
319小時29